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Prolyl isomerases join the fold
Cyclophilins have prolyl isomerase activity, but evidence for their
suggested role in protein folding in cells has been scarce; now they have
been found to accelerate the folding of mitochondrial precursor proteins.
In 1973, Garel and Baldwin [1] discovered that unfolded
ribonuclease A is a mixture of fast-folding and slow-fold-
ing species - the former refold in a few milliseconds,
but the latter take a few minutes to refold. Two years
later, Brandts et al. [2] proposed the 'proline hypothesis'
to explain these results: that fast-folding and slow-folding
molecules differ in the conformational state - cis or trans
- of one or more Xaa-Pro peptide bonds. The sugges-
tion was that, in the fast-folding molecules, the prolyl
peptide bonds are in the same isomeric state as in the
native protein, whereas in the slow-folding molecules,
one or more prolyl peptide bonds are in the incorrect,
non-native isomeric state. It was known already at that
time that, unlike other peptide bonds, those preceding
proline often occur in the cis conformation, and that in
oligopeptides, cis-trans isomerizations about these bonds
are intrinsically slow processes with high activation
energies (- 90 kJ mol- 1).
Slow-folding species were subsequently detected in the
folding of many other proteins [3], and it was speculated
that prolyl isomerizations might retard not only the in
vitro refolding of purified proteins, but also de novo pro-
tein folding in the cell. As a consequence, several labo-
ratories began to search for an enzyme that could
catalyze prolyl isomerization. In 1984, Fischer and his
coworkers [4] devised an ingenious assay for such an
activity and isolated the first prolyl isomerase from
porcine kidney. In vitro, this enzyme - now known as
Cyp18 - accelerated the proline-limited folding reac-
tions of many proteins. The extent of catalysis was gen-
erally good when the prolines remained accessible to
the isomerase during folding [3].
A surprising result emerged when the porcine prolyl
isomerase was sequenced. It was found to be identical to
cyclophilin, the cytosolic binding protein for the
immunosuppressive drug cyclosporin A. In fact, this pro-
tein was discovered twice in 1984: by virtue of its tight
binding to cyclosporin A, and by its catalytic activity as a
prolyl isomerase. A further major surprise came in the
same year when a binding protein for another immuno-
suppressant, FK 506, was discovered. This FK 506-bind-
ing protein, FKBP12, was unrelated to the cyclophilins,
but it was also a prolyl isomerase and catalyzed protein
folding in vitro. Cyclophilins and FKBPs were then dis-
covered in virtually all species and in all cellular compart-
ments, and also as functional domains of larger proteins,
such as Hsp52 or Cyp40 [5,6]. Recently, a third class
of prolyl isomerases, the parvulins, was discovered; these
are not related to the cyclophilins and the FKBPs, and
cannot be inhibited by immunosuppressants [7].
It soon became clear that the functional roles of Cyp18
and FKBP12 in immunosuppression do not involve their
prolyl isomerase activity or the catalysis of a protein fold-
ing reaction. Rather, these proteins are recruited by
cyclosporin A and FK 506, respectively, for association in
tight complexes. These complexes bind to the phos-
phatase calcineurin, and thereby inhibit transport to the
nucleus of a cytosolic component of the transcription
factor NF-AT in T cells [5,6].
So far, the best evidence that the prolyl isomerase activity
of a cyclophilin might be involved in cellular protein
folding has come from studies on the folding of collagen
[8]. Formation of the collagen triple helix is rate-limited
by successive prolyl isomerizations both in vitro and in
vivo. Collagen is resistant to trypsin in the native, but not
in the unfolded state, and triple-helix formation can thus
be followed by protease-pulse experiments. Steinmann et
al. [8] found that the maturation of collagen in chick
embryo fibroblasts is retarded when cyclosporin A is
present, and they proposed that cyclosporin A inhibits a
prolyl isomerase that catalyzes collagen folding in the
endoplasmic reticulum. Recently, a similar effect was
found for the folding of luciferase [9]. Effects of
cyclosporin A on proteins other than cyclophilins could,
of course, not be ruled out in these experiments.
Convincing evidence for catalysis of prolyl isomerization
in cellular protein folding has now been obtained by
Rassow et al. [10] and Matouschek et al. [11]. The two
groups followed the same 'in organelle' strategy, using the
mitochondrial protein-import system to investigate the
potential role of cyclophilins as catalysts of protein fold-
ing. Proteins that are targetted to the mitochondrial
matrix have to be unfolded in order to cross the two
membranes, and then they must refold in the matrix. To
study this refolding reaction, both groups used an artifi-
cial precursor protein composed of the presequence of
subunit 9 of the Neurospora crassa F1F0-ATPase fused to
mouse cytosolic dihydrofolate reductase (Su9-DHFR).
This chimeric protein is efficiently imported into the
matrix of isolated mitochondria, and therefore it has
long been used as a standard substrate for studying the
mechanism of mitochondrial protein import.
In their experiments, the two groups produced
3 5 S-labelled Su9-DHFR by in vitro transcription and
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translation, incubated it in 8 M urea, and then diluted
the unfolded precursor protein into suspensions of
mitochondria from the yeast Saccharomyces cerevisiae and
from N crassa. In both cases, Su9-DHFR was rapidly
imported, the presequence was cleaved off, and the
DHFR moiety refolded in the mitochondrial matrix.
DHFR is an excellent substrate for studying protein mat-
uration in mitochondria: it is rapidly degraded by pro-
teinase K when it is still in non-native states, but not
when it is properly folded.
The refolding of DHFR, as measured by resistance against
proteinase K, showed half times of about 5 minutes in
S. cerevisiae mitochondria at 30 C and in N crassa
mitochondria at 25 C. In both cases, folding was about
five-fold decelerated when the mitochondria had been
preincubated with 2.5-5 pLM cyclosporin A. Similar dif-
ferences in folding rates were observed when Su9-DHFR
refolding was measured in vitro in the presence and
absence of the purified cyclophilin from N crassa mito-
chondria. In S. cerevisiae mitochondria, folding was also
retarded by a non-immunosuppressive variant of cyclo-
sporin, and stable complexes of cyclophilin with other
proteins or refolding precursors could not be detected.
This confirms that cyclophilin acts as an enzyme in mito-
chondrial folding, rather than as a binding protein (as in
immunosuppression).
As in the in vivo experiments with collagen [8], the
observed retardation by cyclosporin A of DHFR refold-
ing in mitochondria provided strong, but not conclusive,
evidence that the effect is indeed caused by inhibition of
the prolyl isomerase activity of mitochondrial cyclophilin.
Both groups went on to demonstrate that DHFR refold-
ing was also retarded in mitochondria derived from S.
cerevisiae and N crassa mutants which lacked a functional
mitochondrial cyclophilin. The kinetics of DHFR
refolding in the mutant mitochondria were almost identi-
cal to those in the presence of cyclosporin A in the wild-
type mitochondria. As expected, cyclosporin A did not
further decelerate these folding reactions. Together, these
results confirm and extend the previous work on the cel-
lular folding of collagen. They provide very strong evi-
dence that the mitochondrial cyclophilin acts as a prolyl
isomerase and thus can catalyze cellular protein folding.
It has long been recognized that slow-folding reactions
create a major problem for in vitro protein folding,
because productive folding is too slow to compete with
the aggregation of partially folded intermediates [12].
Aggregation can be suppressed either by decreasing the
rate of this non-productive reaction itself or by increasing
the rate of productive folding. Both strategies seem to be
used in cellular folding. Aggregation is minimized by the
rapid binding of sticky intermediates to chaperones, such
as the Hsp60s and Hsp70s, and the productive folding
reactions are accelerated by prolyl isomerases.
Major questions still remain. Why are N crassa cells that
lack cytosolic and mitochondrial cyclophilins almost
perfectly viable? Are there 'back-up' systems available,
such as FKBPs, parvulins or other, still unknown, classes
of prolyl isomerases? Or can the cells survive well, even
when protein folding is somewhat retarded? Such a toler-
ance of delayed folding should certainly be an evolution-
ary advantage. It is also not known whether there is a
functional interplay between prolyl isomerases and the
chaperone systems in the mitochondria and elsewhere. It
is now generally assumed that, during Hsp60-mediated
folding, proteins go through many cycles of binding and
ATP-dependent release. By catalyzing productive fold-
ing, the prolyl isomerases should be able to reduce the
number of binding and release cycles, and thus make
folding more efficient and less energy-consuming [10].
The function of the huge number of prolyl isomerases is
certainly not restricted to de novo protein folding. The
link with immunosuppression, the interaction of a host
cyclophilin with the Gag polyprotein of human immuno-
deficiency virus 1, and the stabilization of a calcium-
release channel by an FKBP point to additional functions
(see [5,6] for reviews). Unlike the catalysis of folding,
these functions seem to involve tight binding to the target
molecules. Whether such a binding can affect the cis-trans
isomerization of prolines at the protein surface is not
known yet. Molecular switching by prolyl cis-trans iso-
merization should be possible, but experimental evidence
for this is still lacking.
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